#1 Clinical Trials Search in Europe

Ondansetron Hydrochloride

This article explores the use of Ondansetron Hydrochloride in various clinical trials. Ondansetron Hydrochloride is a medication primarily used to prevent nausea and vomiting. The trials discussed here focus on comparing different formulations of the drug, assessing its bioequivalence under various conditions, and evaluating its effectiveness in treating opioid-induced nausea and vomiting in cancer patients.

Table of Contents

What is Ondansetron Hydrochloride?

Ondansetron Hydrochloride is a medication primarily used to prevent nausea and vomiting. It belongs to a class of drugs called 5-HT3 receptor antagonists, which work by blocking the action of serotonin, a natural substance in the body that can cause nausea and vomiting[1]. This medication is also known by its brand name Zofran, manufactured by GlaxoSmithKline[2].

Uses of Ondansetron Hydrochloride

Ondansetron Hydrochloride is used in various medical situations to prevent or treat nausea and vomiting:

  • Postoperative Nausea and Vomiting (PONV): It’s commonly used to prevent nausea and vomiting after surgery. For example, it’s been studied in patients undergoing vitrectomy (eye surgery) under local anesthesia[4].
  • Chemotherapy-Induced Nausea and Vomiting: While not explicitly mentioned in the provided studies, this is a common use for ondansetron.
  • Prevention of Hypotension During Cesarean Section: Interestingly, ondansetron has been studied for its potential to prevent low blood pressure (hypotension) in women undergoing cesarean sections under spinal anesthesia[1].

How is Ondansetron Administered?

Ondansetron Hydrochloride can be administered in several ways:

  • Tablets: It’s available in tablet form, typically in doses of 8 mg or 24 mg[2][5].
  • Intravenous (IV) Injection: In hospital settings, it can be given as an injection into a vein. For example, in one study, 4 mg was given intravenously before surgery[4].

The dosage and method of administration depend on the specific medical situation and the patient’s needs.

Effectiveness of Ondansetron

Research has shown that ondansetron is effective in preventing nausea and vomiting in various situations:

  • In a study on patients undergoing eye surgery (vitrectomy), ondansetron was compared to other anti-nausea medications for its effectiveness in preventing PONV[4].
  • Another study investigated its potential to prevent low blood pressure during cesarean sections. This research suggests that ondansetron may have additional benefits beyond just preventing nausea and vomiting[1].

Potential Side Effects

While the provided studies don’t explicitly list side effects, it’s important to note that all medications can have potential side effects. Common side effects of ondansetron may include headache, constipation, and dizziness. Always discuss potential side effects with your healthcare provider.

Ongoing Research

Ondansetron continues to be the subject of ongoing research:

  • Bioequivalence Studies: Several studies are comparing different formulations of ondansetron to ensure they work the same way in the body. These studies look at how the drug is absorbed and processed under different conditions (fasting and non-fasting)[2][3][5][6].
  • Interaction with Other Medications: One study is investigating potential interactions between ondansetron and acetaminophen (paracetamol) in post-operative pain management after thyroid surgery[7].

These ongoing studies help ensure the safety and effectiveness of ondansetron in various medical situations and in combination with other treatments.

Aspect Details
Drug Studied Ondansetron Hydrochloride
Main Purpose Assess bioequivalence of different formulations and effectiveness in treating nausea and vomiting
Study Conditions Fasting and fed conditions
Formulations Tested Tablets (8mg and 24mg), Orally Disintegrating Tablets (ODT)
Comparisons Made Generic vs. Brand-name (Zofran), Ondansetron vs. Aprepitant
Key Measurements Area Under Curve (AUC), Maximum Concentration (Cmax)
Special Focus Opioid-Induced Nausea and Vomiting in cancer patients

FAQ

  • What is the main purpose of the Ondansetron Hydrochloride clinical trials? The main purpose of these trials is to compare different formulations of Ondansetron Hydrochloride, assess their bioequivalence (how similar they are in terms of how the body processes them), and evaluate their effectiveness in treating nausea and vomiting under various conditions.
  • What does 'bioequivalence' mean in the context of these trials? Bioequivalence refers to the comparison of different drug formulations to determine if they have the same effect in the body. In these trials, researchers are comparing generic versions of Ondansetron Hydrochloride to the brand-name version (Zofran) to ensure they work similarly.
  • What conditions were the trials conducted under? The trials were conducted under different conditions, including fasting (when participants hadn't eaten) and fed (after participants had eaten) conditions. This helps researchers understand how food might affect how the drug works in the body.
  • What is an 'orally disintegrating tablet' mentioned in one of the trials? An orally disintegrating tablet is a type of medication that quickly dissolves in the mouth without needing water. One of the trials compared this form of Ondansetron Hydrochloride to the regular tablet form.
  • Was Ondansetron Hydrochloride compared to any other medications in these trials? Yes, in one trial, Ondansetron Hydrochloride was compared to another medication called aprepitant for treating opioid-induced nausea and vomiting in cancer patients. This helps researchers understand which medication might be more effective for this specific use.

Ongoing Clinical Trials on Ondansetron Hydrochloride

  • Study on Preventing Persistent Postoperative Pain in Children Using Mepivacaine Hydrochloride and Drug Combination

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • A Study to Evaluate LY3537021 and a Drug Combination for Treating Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Romania Spain

  • Study of AZD9550 and AZD6234 combination for weight loss in people with obesity or overweight with health complications

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Safety and Effects of THOR-707 and Drug Combination in Adults with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Safety and Effects of mRNA-3745 for Patients with Glycogen Storage Disease Type 1a (GSD1a)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands Poland Spain

Glossary

  • Bioequivalence: A term used to describe when two medications are expected to have the same effect on the body. In these trials, it refers to comparing generic versions of Ondansetron Hydrochloride to the brand-name version.
  • Area Under Curve (AUC): A measurement used in drug trials to show the total exposure to a drug over time. It helps researchers understand how much of the drug is in the body and for how long.
  • Cmax: The maximum concentration of a drug in the blood after it's been taken. This helps researchers understand how much of the drug reaches the bloodstream.
  • Orally Disintegrating Tablet (ODT): A type of tablet that quickly dissolves in the mouth without needing water. This can be helpful for patients who have trouble swallowing pills.
  • Opioid-Induced Nausea and Vomiting (OINV): Nausea and vomiting that occurs as a side effect of taking opioid medications, which are often used for pain relief.
  • Fasting Condition: A state where a person hasn't eaten for a certain period before taking a medication. This helps researchers understand how the drug works without interference from food.
  • Fed Condition: A state where a person has eaten before taking a medication. This helps researchers understand how food might affect how the drug works in the body.

References

  1. https://clinicaltrials.gov/study/NCT04703088
  2. https://clinicaltrials.gov/study/NCT01511705
  3. https://clinicaltrials.gov/study/NCT01511718
  4. https://clinicaltrials.gov/study/NCT02386059
  5. https://clinicaltrials.gov/study/NCT00946387
  6. https://clinicaltrials.gov/study/NCT00947128
  7. https://clinicaltrials.gov/study/NCT01679093